AR028281A1 - DERIVATIVES OF 2- (ARILALQUILAMINO) PIRIMIDONA AND DERIVATIVES OF 2- (HETEROAROARILALQUILAMINO) PIRIMIDONA - Google Patents
DERIVATIVES OF 2- (ARILALQUILAMINO) PIRIMIDONA AND DERIVATIVES OF 2- (HETEROAROARILALQUILAMINO) PIRIMIDONAInfo
- Publication number
- AR028281A1 AR028281A1 ARP010101373A ARP010101373A AR028281A1 AR 028281 A1 AR028281 A1 AR 028281A1 AR P010101373 A ARP010101373 A AR P010101373A AR P010101373 A ARP010101373 A AR P010101373A AR 028281 A1 AR028281 A1 AR 028281A1
- Authority
- AR
- Argentina
- Prior art keywords
- pirimidona
- derivatives
- heteroaroarilalquilamino
- arilalquilamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000081938A JP2001270884A (en) | 2000-03-23 | 2000-03-23 | Pyrimidone derivative |
EP00400805A EP1136099A1 (en) | 2000-03-23 | 2000-03-23 | 2-(Indolylalkylamino)pyrimidone derivatives as GSK3beta inhibitors |
EP00400806A EP1136491A1 (en) | 2000-03-23 | 2000-03-23 | 2-[(Heteroaryl)alkylamino]pyrimidone derivatives |
EP00400804A EP1136484A1 (en) | 2000-03-23 | 2000-03-23 | 2-(Arylalkylamino)pyrimidone derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AR028281A1 true AR028281A1 (en) | 2003-04-30 |
Family
ID=27440051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010101373A AR028281A1 (en) | 2000-03-23 | 2001-03-23 | DERIVATIVES OF 2- (ARILALQUILAMINO) PIRIMIDONA AND DERIVATIVES OF 2- (HETEROAROARILALQUILAMINO) PIRIMIDONA |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR028281A1 (en) |
AU (1) | AU2001248365A1 (en) |
WO (1) | WO2001070727A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1197621C (en) | 2000-04-26 | 2005-04-20 | 卫材株式会社 | Medicinal compositions promoting bowel movement |
TWI335221B (en) * | 2001-09-27 | 2011-01-01 | Alcon Inc | Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
TWI301834B (en) * | 2001-10-22 | 2008-10-11 | Eisai R&D Man Co Ltd | Pyrimidone compound and pharmaceutical composition including the same |
TWI330183B (en) | 2001-10-22 | 2010-09-11 | Eisai R&D Man Co Ltd | |
US20050203059A1 (en) * | 2002-03-01 | 2005-09-15 | Harrison Stephen D. | Methods and compositions for treatment of ischemia |
EP1925306A3 (en) * | 2002-04-30 | 2008-09-17 | Alcon, Inc. | Agents which Regulate, Inhibit, or Modulate the Activity and/or Expression of Connective Tissue Growth Factor (CTGF) to Lower Intraocular Pressure |
PL378030A1 (en) | 2002-04-30 | 2006-02-20 | Alcon, Inc. | Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies |
WO2004037791A1 (en) | 2002-10-21 | 2004-05-06 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
EP1713793A4 (en) * | 2004-02-04 | 2009-09-02 | Smithkline Beecham Corp | Pyrimidinone compounds useful as kinase inhibitors |
CA2593612A1 (en) | 2005-01-07 | 2006-07-13 | Emory University | Cxcr4 antagonists for the treatment of hiv infection |
CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
EP2377530A3 (en) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
JP2009513672A (en) | 2005-10-31 | 2009-04-02 | ブレインセルス,インコーポレイティド | GABA receptor-mediated regulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
CA2651813A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
JP2009543802A (en) * | 2006-07-11 | 2009-12-10 | エモリー・ユニバーシテイ | CXCR4 antagonists containing diazine and triazine structures for the treatment of medical diseases |
JP2009543874A (en) * | 2006-07-18 | 2009-12-10 | ユニバーシティー オブ ロチェスター | Thiazolidinone derivatives |
WO2008023239A1 (en) * | 2006-08-23 | 2008-02-28 | Pfizer Products Inc. | Pyrimidone compounds as gsk-3 inhibitors |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
CN101917980B (en) * | 2007-11-01 | 2013-12-11 | 奥克塞拉有限公司 | Amine derivative compounds for treating ophthalmic diseases and disorders |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002514195A (en) * | 1996-12-05 | 2002-05-14 | アムジエン・インコーポレーテツド | Substituted pyrimidine compounds and uses thereof |
-
2001
- 2001-03-22 AU AU2001248365A patent/AU2001248365A1/en not_active Abandoned
- 2001-03-22 WO PCT/EP2001/003638 patent/WO2001070727A1/en not_active Application Discontinuation
- 2001-03-23 AR ARP010101373A patent/AR028281A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001070727A1 (en) | 2001-09-27 |
AU2001248365A1 (en) | 2001-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR028281A1 (en) | DERIVATIVES OF 2- (ARILALQUILAMINO) PIRIMIDONA AND DERIVATIVES OF 2- (HETEROAROARILALQUILAMINO) PIRIMIDONA | |
AR028567A1 (en) | NEW DERIVATIVES OF FENIL-PROPARGILETER | |
AR028596A1 (en) | NEW DERIVATIVES OF PHENYLGLYCIN | |
NO20025978L (en) | Benzothiazole derivatives | |
ID30590A (en) | ONCE USE SHORT TYPE OF SHORT-PANTS | |
AR028253A1 (en) | INHIBITORS OF THE GLUCOGENO FOSFORILASA | |
MA27126A1 (en) | 3'PROMEDICAMENTS OF 2'-DESOXY- β-L-NUCLEOSIDES | |
AR027938A1 (en) | URACILO COMPOUNDS AND USE OF THE SAME | |
DE60134338D1 (en) | PIPERAZIN DERIVATIVES | |
DK1292604T3 (en) | 2-aminocarbonyl-9H-purine derivatives | |
DE60043343D1 (en) | CHROME DERIVATIVES | |
DE50112013D1 (en) | DEODORANTIA AND ANTIPERSPIRANTIES | |
ID30187A (en) | DONGKRAK KIND OF PANTAGRAF | |
ATE298332T1 (en) | DECAHYDRO-ISOCHINOLINE DERIVATIVES | |
DK1280809T3 (en) | Antitumorecteinascidin derivatives | |
AR028602A1 (en) | PIRROL DERIVATIVES | |
PT1246817E (en) | DERIVATIVES OF 4-PHENYL-1-PIPERAZINYL, -PIPERIDINYL E-TETRAHYDROPYRIDYL | |
PT1322592E (en) | SUBSTITUTED DERIVATIVES OF 1-AMINOBUTAN-3-OL | |
DE60032898D1 (en) | ARYLTHIAZOLIDEINDION AND ARYLOXAZOLIDINE DERIVATIVES | |
DE60117096D1 (en) | DIHYDROINDOL AND TETRAHYDROCHINOLINE DERIVATIVES | |
ATE280752T1 (en) | AMINOMETHYL-PHENYL-CYCLOHEXANONE DERIVATIVES | |
PT1178984E (en) | DERIVATIVES OF 1-TRIFLUOROMETHYL-4-HYDROXY-7-PIPERIDINYLAMIMOME | |
PT1392670E (en) | SUBSTITUTED DERIVATIVES OF C-FURAN-2-IL-METHYLAMINE AND C-THIOFEN-2-IL-METHYLAMINE | |
AR027964A1 (en) | COMBINATION OF THERMOPLASTIC EPNXIC FIBERS AND DERIVATIVES | |
DE60007360T2 (en) | AMORPHE MODIFICATION OF TORASEMID |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |